Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Ecri Bv, explained in plain language.
This study tests whether ziltivekimab, a drug that reduces inflammation, can improve artery health in people who recently had a heart attack. About 332 participants will receive either ziltivekimab or a placebo, along with standard care, for 15 months. Special imaging will measur…
Phase: PHASE3 • Sponsor: ECRI bv • Aim: Disease control
Last updated May 26, 2026 05:30 UTC